COVID-19 Clinical Trial
Official title:
Communicating Uncertainty About the Effects of Wearing Glasses to Reduce the Chance of Getting COVID (Corona Virus Disease): Protocol for a Randomized Trial
Verified date | May 2024 |
Source | Trustees of Dartmouth College |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Randomized trial testing 6 forms of a communication summarizing the results of a recent study (about the effects of wearing glasses on reducing covid infection risk). The goal of the trial is to test the effect of different language options to describe uncertainty, and of including the margin of error around the main result.
Status | Completed |
Enrollment | 960 |
Est. completion date | March 31, 2023 |
Est. primary completion date | January 31, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - >= 18 years old - literate in English or Norwegian - currently residing in Norway or the United States Exclusion Criteria: - individuals who regularly wear any kind of glasses (i.e., prescription or sunglasses) all or most of the time |
Country | Name | City | State |
---|---|---|---|
Norway | Norwegian Institute of Public Health | Oslo |
Lead Sponsor | Collaborator |
---|---|
Trustees of Dartmouth College | Norwegian Institute of Public Health |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | understanding of overall uncertainty of benefit (of wearing glasses to reduce the chance of covid infection) | How sure about the effect (4 point scale from very unsure to very sure) | within 1 day | |
Primary | understanding of overall uncertainty of harm (of wearing glasses to reduce the chance of covid infection) | How sure about the effect (4 point scale from very unsure to very sure) | within 1 day | |
Primary | sufficiency of what is known about the effects of wearing glasses to reduce the chance of covid infection | How sure about the effect (4 point Likert scale) | within 1 day | |
Primary | Understanding the margin of error around the benefit of wearing glasses to reduce covid | this is a co-primary outcome which will be used only to compare the 3 versions that include the margin of error to the 3 versions that do not | within 1 day | |
Secondary | perceived effect of wearing glasses to reduce chance of covid infection | What is the effect on a 5 point scale (lowers a lot, lowers a little, no effect, increase a little, increases a lot | within 1 day | |
Secondary | how likely is it that wearing glasses reduces the chance of covid infection | 4 point scale (very likely, likely, unlikely, very unlikely) | within 1 day | |
Secondary | intended behavior (if there were a surge in covid in your area, how likely would you be to wear glasses to reduce the chance of covid infection | 4 point scale (very likely, likely, unlikely, very unlikely | within 1 day | |
Secondary | intended behavior (if there were very few cases of covid in your area, how likely would you be to wear glasses to reduce the chance of covid infection | 4 point scale (very likely, likely, unlikely, very unlikely | within 1 day | |
Secondary | perceptions fo information provided (trustworthy summary?) | 4 point Likert scale (strongly agree, agree, disagree, strongly disagree) | within 1 day | |
Secondary | perceptions fo information provided (sufficient summary?) | 4 point Likert scale (strongly agree, agree, disagree, strongly disagree) | within 1 day | |
Secondary | perceptions fo information provided (clarity of info about benefit) | 4 point scale (very clear, clear, unclear, very unclear) | within 1 day | |
Secondary | perceptions fo information provided (clarity of info about harm) | 4 point scale (very clear, clear, unclear, very unclear) | within 1 day | |
Secondary | perceptions fo information provided (info helpful?) | 4 point scale (very helpful, helpful, unhelpful, very unhelpful) | within 1 day | |
Secondary | perceptions fo information provided (share info with others?) | 4 point scale (definitely yes, probably yes, probably no, definitely no) | within 1 day | |
Secondary | Decisional conflict (hard to make decision) | 4 point LIkert scale (strongly agree, agree, disagree, strongly disagree) | within 1 day | |
Secondary | Decisional conflict (made informed decision) | 4 point LIkert scale (strongly agree, agree, disagree, strongly disagree) | within 1 day | |
Secondary | Decisional conflict (satisfied with decision) | 4 point LIkert scale (strongly agree, agree, disagree, strongly disagree) | within 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|